Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 51Oligometastatic Prostate Cancer 2Neoplasm Metastasis 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2Metastatic Castration-resistant Prostate Cancer 2Triple Negative Breast Neoplasms 1Stage IV Prostate Adenocarcinoma AJCC v7 1Prostate CA 1Prostate Adenocarcinoma 1PSA Level Greater Than 0.03 1Non-metastatic, Hormone naïve Prostate Cancer 1Lymphatic Metastasis 1Hormone Sensitive Prostate Cancer 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Surgical Procedures, Operative 1Radiosurgery 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate CA × Androgen Antagonists × Clear all
NCT06834321 2025-09-08

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Zhongda Hospital

Phase 2 Recruiting
96 enrolled
Genitourinary

Prostate CA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡